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ABSTRACT
Over the last decade a number of peptides that are rapidly internalized by
mammalian cells have been discovered or designed. Cell-penetrating peptides (CPPs) are
capable of mediating penetration of the plasma membrane, allowing delivery of
macromolecular cargoes to the cell interior. We have developed a novel CPP-adaptor
protein technology that allows any user-defined cargo delivery and release into the
cytoplasm. Our hypothesis is that a CPP-adaptor with a moiety allowing high-affinity but
reversible non-covalent cargo binding would lead to more efficient penetration and
release than current CPP delivery strategies. Delivery of proteins to the interiors of cells
has many applications. In addition to detecting and mapping the location of the
components of living cells with fluorescent tags in real time, the availability of our
system will likely enable the manipulation of signaling pathways and gene expression by
allowing the introduction of components, e.g. constitutively active kinases, repressors or
enhancers.
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CPP-adaptor, TaT-Calmodulin, and cargo proteins (horse radish peroxidase,
myoglobin and beta-galactosidase) were expressed and purified from E. coli BL21
(DE3)pLysS. Optical biosensing experiments demonstrated that affinity and kinetics
between the novel CPP and cargo proteins did not significantly differ from wild-type
interactions; all had subnanomolar affinities. Cargo proteins were labelled with DyLight
550. CPP-cargo complexes or cargo alone were incubated with subconfluent baby
hamster kidney, HEK 293T and HT-3 cells. After washing, cells were imaged by
fluorescence confocal microscopy. All users define cargos exhibited penetration and
release to the cytoplasm whereas cargo-only controls exhibited no measurable penetration
(though some adherence to the outside of the cells was observed). Time courses and
dose-dependency studies characterizing penetration and release kinetics will be presented
as will initial efforts to deliver cargo that may alter cell-signaling pathways.
The results presented herein demonstrate the feasibility of delivering a wide
variety of cargo proteins to the intracellular environment; creating an array of potential
research, diagnostic and therapeutic applications.
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1.

INTRODUCTION

The plasma membrane of cells has a very selective barrier with regard to
molecules of varying properties. This phospholipid bilayer is important for cell survival
and function, but prevents the delivery of hydrophilic and other cargos such as
therapeutic drugs, information rich molecules including oligonucleotides, genes, peptides
or proteins (1, 2). For example, oligonucleotides have therapeutic potential as
pharmacological agents, but their high molecular weights and charge densities present a
challenge for intracellular delivery(3). It has also been a challenge for these hydrophilic
molecules to cross the blood-brain barrier (BBB); a route that helps with the transport of
therapeutic agents from the vasculature into the brain parenchyma (1). To develop the
technology of exogenous delivery of molecules into living cells, molecular transporters
have been sought.
Several strategies have been developed to deliver therapeutic agents into cells
across cellular membranes. Pharmaceutical carriers, such as nanospheres, nanocapsules,
liposomes, micelles, cell ghosts, lipoproteins, and polymers have been used to deliver
some therapeutic and diagnostic agents. Some of these carriers are nanometers in size and
can be coated with polyethylene glycol (PEGylated) to form ‘stealth’ nanocarriers (4,
5).The delivery with these carriers is based on passive accumulation in the pathological
regions making it difficult for cargos to be efficiently delivered to the target location.
Other delivery methods, transfection, have also been used to translocate macromolecules
such as DNA. Transfection techniques include microinjection, electroporation and
1

liposome and viral-based vectors. The downsides with transfection techniques include
low efficiency, high toxicity and poor specificity (6). Transfection with DNA into cells to
produce genetically modified cells has additional drawbacks including the need for
transcription and translation, and the lack of control of intracellular concentration.
Viral vectors have also been used for intracellular delivery, but the introduction of
a viral vector may cause an inflammatory reaction or an insertional mutation (7). This is
because viral genomes can integrate into the host genome randomly, which may disrupt
tumor suppressor genes, activate oncogenes, or interrupt essential genes. Another
disadvantage of this method is that a virus package has limited space for a foreign gene
while maintaining infectivity. Viruses also disrupt the normal cellular functions of their
hosts after they invade the cell. Viral proteins compete with host proteins hence
destabilizing regular host protein–protein interactions (8). For example the HIV-1
genome has three standard retroviral genes (gag, pol, and env) which in addition to the
auxiliary genes (vif, vpr, vpu, and nef) and the 2 regulatory genes (tat and rev); engage in
a wide range of interactions between the host’s proteins and viral proteins (8-10).
The discovery and characterization of HIV-I TaT protein gave insight on
translocation of large and hydrophilic molecules into the cell with less toxicity and high
efficiency. TaT was the first of many peptides now known as cell-penetrating peptides
(CPPs) to translocate the plasma membrane. For the purpose of this project, we
constructed CPPs-coupled adaptors for protein cargo delivery into the cell. CPPs and
potential cargos are discussed in the next sections.
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1.1.

What are cell penetrating peptides?
CPPs are short peptides ranging between 5-30 amino acid residues. They

have the capacity to ubiquitously cross cellular membranes with very limited toxicity
through energy-dependent and/or independent mechanisms with specific receptors (11). It
is promising that CPP-mediated delivery of macromolecules in vivo will be successful
because in vitro experiments show transport. CPPs occur naturally and can also be
synthesized. Natural CPPs include : HIV-1 TaT peptide which was derived from the
human immunodeficiency virus type 1 transcription activating factor(2, 12, 13),
Antennapedia (Antp43-58), also known as penetratin, was obtained from Drosophila
Antennapedia homeodomain transcriptional factor(14-16), pVEC was from murine
vascular endothelial cadherin (17), buforin II was a histone-derived antimicrobial peptide
(18), and VP22 was from Herpes simplex virus (HSV) type I structural protein (19-21).
Oligoarginine peptides (22, 23), amphipathic peptide (24), and transportan (25) are some
designed synthetic CPPs. Much precaution is required when designing CPPs in-order to
avoid low yields, poor solubility, aggregation, or toxicity.
Since the discovery of the first CPPs, several different CPPs have been shown to
deliver proteins, therapeutic drugs, nucleic and other cargos into the cell (Table 1). CPPs
have gained attention in both medical and biological sciences not just because they can to
internalize in vitro and in vivo, but also because of the potential for variable modification
design (26).
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1.1.1. Classification of CPPs
The most common way to classify CPPs is based on origin, synthetic or natural.
The natural CPPs are truncated versions of proteins and have been classified in subgroups
depending on the chemical properties: cationic, amphipathic, and hydrophobic.
1.1.2. Cationic CPPs
Cationic CPPs are peptides with a high positive net charge because, they are rich
in arginine and lysine. It has been suggested that at least six to eight positive charges are
needed for efficient uptake of several cationic CPPs (26, 27). Initially, cationic CPPs
were used as delivery tools without any cellular response, but it was later discovered that
they induced a wide range of side effects, including effects on membrane integrity and
cell viability, which might be more subtle than cell death (15, 26, 28).
1.1.3. Amphipathic CPPs
Amphipathic CPPs on the other hand are peptides which contain both polar and
non-polar groups. The amphipathic nature of these peptides may evolve from the primary
structure of the protein (26). Amphipathic CPPs may be derived either from natural
proteins such as pVEC or by covalent linkage of a hydrophobic domain to a nuclear
localization signal sequence e.g MPG (table 1)(26).
1.1.4. Hydrophobic CPPs
Hydrophobic CPPs only have non-polar residues and typically have low net
charge. Part of the amphipathic CPPs, such as MAP (table 1) contains some
hydrophobicity (26).
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Table 1: Classes of cell penetrating peptides (26)
Type
Amphipathic

Cationic

Hydrophobic

1.2.

Name
Transportan
Pep-1
MPG
pVec
MAP
CADY
Polyarginie
Tat49-57
Penetrtin (pAntp)
DPV3
Pep-7
G3

Amino acid Sequence
GWTLNSAGYLLGKINLKALAA
KETWWETWWTEWSQPKKRKV
GALFLGWLGAAGSTMGAPKKKRKV
LLIILRRRIRKQAHAHSK
KLALKLALKALKAALKLA
GLWRALWRLLRSLWRLLWRA
R8, R9 , R10
RKKRRQRRR
RQIKIWFQNRRMKWKK
RKKRRRESRKKRRRES
SDLWEMMMVSLACQY
RLSGMNEVLSFRWL

Objectives of this study

The goal of this thesis project was to develop an array of tools for intracellular
protein delivery. The main objectives were to develop and optimize a new cell
penetrating peptide adaptor. To test protein-protein interactions of the CPP-adaptor, TaTCaM, with natural calmodulin proteins and recombinant calmodulin proteins. To test the
new CPP-adaptor for the ability to deliver one or more cargo proteins into living cells.
Achieving the above goals, would enable us to design, produce and screen alternate CPP
constructs as time and resources allowed, utilizing CPP moieties of other penetrance
modes, e.g. amphipathic, hydrophobic, cationic. A long term goal of the project will be to
use the CPP-adaptor system to deliver a protein that alters cellular morphology, such as
being able to deliver a tumor suppressor protein to cells lacking it, inducing senescence.
1.3.

Novel CPP-adaptors discussed in this thesis
The CPP-adaptor, TaT-CaM, consists of the cell penetrating sequence

from the HIV transactivator of transcription (12) fused to calmodulin, a calcium sensor
5

protein. The addition of calmodulin allows any cargo with a calmodulin binding site
(CBS) to bind TaT-CaM resulting in a transducible entity. Before going into details in
chapter 2 describing the construction of the CPP-adaptor, TaT protein, Antennapedia,
Calmodulin and a naturally calmodulin protein, nNOS will be discussed briefly here.
1.3.1. Transactivation of Transcription (TaT) peptide
TaT is an early regulatory protein of the HIV-1 genome. The size of TaT varies
from 86-104 amino acid residues in length and is encoded by two exons (8, 29, 30). This
transactivation protein contributes to the activation of viral and cellular genes. A double
splicing mechanism occurs where TaT is split off the TaT mRNA transcript and this
cytoplasmic TaT is directed into the nucleus by a nuclear localization signal where it
activates the viral genome (Figure 1A) (31). HIV-I TaT functions in chromatin
remodeling, phosphorylation of RNA polymerase II that is involved in the transcription
of the full-length viral mRNAs, transactivation of viral genes, and binding to a specific
structure of HIV-I mRNA (32-35). These functions are necessary for the HIV gene
expression in which TaT is the activator that overcomes the cellular barrier of mRNA
transcription (8). TaT does this by recruiting cellular proteins which relieve the
repression of the viral long-terminal repeat (LTR), thereby enabling the viral promoter to
induce the expression of viral genes (32). Other TaT functions include the upregulation of
cytokines expression levels, the HIV-1 co-receptor CCR5 and the interleukin-2 (IL-2)
receptor (CD25) in HIV-1-infected cells (8). Upregulation of cellular genes by TaT
induces effects such as apoptosis (36).
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Figure 1A: HIV-1 early gene expression. Genome-length RNA is
transcribed then much of it is spliced, giving rise to two further size classes
of RNA that can be detected in northern blots of RNA from infected cells.
Early in infection most of the RNA is multiply spliced and is transported to
the cytoplasm, where the TaT, Rev and Nef proteins are translated. Nef is
myristylated and performs a number of roles in the cytoplasm, while TaT
and Rev are transported to the nucleus. Northern blot from Malim M.H. et
al. (1990) Cell, 60, 675.

Mutation studies have shown that only the 72 N-terminal residues are required for
TaT functions in cellular internalization, and truncated TaT residues 48-60 from the
protein transduction domain are responsible for internalization (11-13, 37). TaT48-60
region is made up of mostly basic amino acids, six arginine and two lysine residues
(Table 1; Figure 1B). Arginine forms more stable hydrogen bonds with phosphoryl
groups at physiological temperature due to its guanidinium group on the side chain (38),
and could also form stable interactions with the carboxyl, phosphoryl, and sulfuryl groups
7

on the cell surface, thereby facilitating endocytosis (39). This positive-negative
interaction facilitates the initial entry step of TaT. Studies reveal that TaT48-60 peptide is
taken up by cells with concentrations as low as 1nmole and is not cell type specific (13).
CD data and other physiochemical techniques confirmed the region of TaT covering 38–
49 domains has an α-helical structure with amphipathic characteristics (40).

Figure 1B: The structure of full length TaT showing the basic arginine rich TaT 47-57
peptide. The protein transduction domain consist of a basic domain with one amino acid
from the central domain (42)

1.3.2. Antennapedia (Penetratin)
The antennapedia homeotic gene
is necessary for correct development of
thoracic segments in both larval and adult
stages of Drosophila. Loss of function of
this gene results in lethality in embryos or
larvae. The thoracic cuticle may also be
transformed into structures that are more
Figure 2: The 60 amino acids sequence of Antennapedia
showing the third helix sequence from 43-58 (46)
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anterior thorax or to the head (41, 42). Cell developmental fate to some extent depends
on the homeobox( antennapedia) protein. Homeodomain proteins like antennapedia are a
class of transcription factors involved in many morphological processes that are from
embryonic development to terminal differentiation. These family of proteins typically
consists of three α-helices with one β-turn between helix 2 and 3 (figure 2) and bind to
the DNA through a sequence of 60 amino acids (15, 43). Through studies of the binding
region of the homeodomain, the amino acids sequence has been shown to enter neuronal
cells and translocate to the nuclei (43). Mutation studies were able to identify the regions
capable of this internalization, and have shown that a 16 amino acid sequence located in
the third helix was responsible for translocation (15, 44). It was for this reason that
antennapedia was considered a cell penetration peptide.

1.3.3. Calmodulin
The primary adaptor used for the novel
CPPs is this project is Calmodulin (CaM). Since
TaT has been shown to translocate the plasma
membrane, we coupled CaM to TaT forming TaTCaM for protein cargo translocation. CaM is the
major calcium-binding protein that binds and
regulates a multitude of different protein targets in
all eukaryotes (45). CaM has the ability to bind up

Figure 3: Structure of free CaM (apoCaM) [A,
shown by nuclear magnetic resonance (NMR)]
and bound CaM (Ca2+CaM) (B, shown by X-ray
diffraction) (119).

to four calcium ions (Figure 3 (46), which induces a conformational change and renders
CaM active and ready to carry out regulatory functions. The Ca2+/CaM complex interacts
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with many different proteins and might cause either activation or inhibition (47). CaM
mediates processes such as inflammation, metabolism, apoptosis, muscle contraction,
intracellular movement, short-term and long-term memory, nerve growth, and the
immune response. It can be expressed in many cell types and has different subcellular
locations, including the cytoplasm, within organelles, or associated with the plasma or
organelle membranes (48).
We selected CaM because it is one of the most abundant, ubiquitous, and
conserved proteins in eukaryotes (46), which allowed us to hypothesize that it would be
tolerated well. CaM binding sites are located within regulated proteins such that when it
binds, it forces a conformational thus enabling or inhibiting the partner protein (49). In
the absence of calcium, the N-terminal domain of calmodulin is closed while the Cterminal is semi-open. In this case, the C-terminal might interact with some target
proteins (46), which may be why some proteins do not depend on the Ca2+/CaM complex
for activities e.g inducible Nitric Oxide Synthase (iNOS).

1.3.4. Nitric Oxide Synthase (NOS)
eNOS, nNOS, and iNOS are the isoforms of NOS that are responsible for nitric
oxide (NO) released from L-arginine (50-52). NO is a key determinant of endothelial
function. It also functions as a neurotransmitter, a signal in skeletal muscle, an adaptive
signal for developmental and growth of new blood vessels (angiogenesis) and a regulator
of insulin control (52). Studies have shown that eNOS and nNOS depend on Ca2+/CaM
for enzymatic activity (50, 53). iNOS does not depend on Ca2+/CaM for activation but
rather on the genes encoding it at the level of transcription (54).
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NOS is active as a dimer and dimerization requires tetrahydrobiopterin (BH4),
heme and L-arginine binding (55, 56). Each monomer contains an N-terminal oxygenase
domain and a C-terminal reductase domain. The oxygenase domain contains the substrate
and BH4 binding sites while the reductase domain has the FAD, FMN, and NADPH
cofactor binding sites (55) (Figure 4). The calmodulin binding site lies between the
oxygenase and reductase domains. nNOS as a canonical calmodulin protein was first
used to obtain preliminary data for this project. The binding kinetics of nNOS with TaTCaM gave similar results as nNOS with wild type CaM (57).

Figure 4: Structural cartoon of NOS reductase domains based on the
nNOS reductase crystal structure. The FMN-binding domain is in blue,
the FAD-binding domain green and the NADPH-binding domain is tan.
Cofactors are shown in solid render and the residues at the N-terminal
edge of the FMN-binding domain(59)
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1.4. Calmodulin binding proteins expressed in E.coli
Recombinant CaM binding proteins that are expressed in E.coli were optimized as
potential cargos for the new CPP-adaptor. E.coli is a robust, convenient, and inexpensive
expression system for the production and purification of human proteins (58). CPPadaptor proteins and cargo proteins were expressed in BL 21 cells. These cells contain a
T7 RNA polymerase gene integrated into the genome and are under control of the
lacUV5 promoter, a lactose analog (IPTG) inducible system. BL 21 (DE3) pLysis strains
contained the plasmid that encode T7 lysozyme gene. T7 lysozymes inhibit T7 RNA
polymerase hence reducing basal expressions of target genes. This provides a tight
control of T7 RNA polymerase which is necessary when the recombinant protein to be
expressed is toxic (59). A list of CaM binding proteins that have been expressed in
bacteria is shown in Table 2. Other cargos that we were interested in, but that lacked the
CaM binding sites, were cloned into the vector pCAL-n-Flag (60) between BamHI and
HindIII restriction sites.
Table 2: Calmodulin binding proteins
Cam binding proteins

Function

reference

NOS synthase

Catalyzes the production of NO from L-arginin

(61, 62)

Calcineurin

Regulate transcription faction NF-AT during T-

(63-65)

cells activation
P68 RNA helicase

Involved in the processing of pre-RNA, rRNA,

(66, 67)

and miRNA
Myosin light chain kinase Phosphorylates myosin in the presence of

(68, 69)

Ca2+/CaM thereby activating myosin so that it
can interact with actin in smooth muscles
Alpha spectrin

In red blood cells, it forms a meshwork that

12

(69, 70)

supports the plasma membrane and defines the
biconcave shape of the cell.
Ribosomal protein L9

Encodes the ribosomal protein that is a

(71-73)

component of the 60S subunits
Ribosomal protein S8

Primary binding protein that binds

(74, 75)

independently to the central domain of 16S
rRNA and is required for proper assembly of
the 30S ribosomal subunit
P62

A putative RNA binding protein that may

(76, 77)

facilitate transport out of the nucleus.
NAD kinase

Phosphorylates NAD to NADP. Both

(78, 79)

NAD/NADP in addition to being electron
carriers, are also involved in process like signal
transduction, transcription, DNA repair, and
detoxification reactions

1.5. Mechanisms of CPPs uptake
The mechanism of CPPs internalization remains a challenge even though a lot of
studies have been done since the first discovery. Understanding the modes of
translocation and intracellular delivery of cargos is an important step for optimization of
the delivery systems. Biological and biophysical techniques have been used to follow up
CPP penetration and cargo delivery into the cell. Several groups hypothesized that
translocation occurs either by endocytosis or direct penetration of the peptide with or
without its cargo (Figure 5). The mechanism used depends on the chemical and physical
properties of the CPPs, the concentrations used, the biophysical properties, and the size of
the cargo and the cell type it has to translocate (5, 80).
13

Figure 5: Intracellular pathways of cell entry for cell-penetrating
peptides (CPPs)(5)

1.5.1. Direct penetration
Possible modes of CPP translocation through the membrane include; inverted
micelle formation, pore formation, and the carpet-like model (81).
Inverted Micelle: This mechanism of uptake was first shown with penetratin (82).
This model involves the interaction of basic residues with the negatively charged
phospholipids in the plasma membrane. Interaction destabilizes the bilayer, resulting in
invagination of the membrane (11). With the rearrangement of the neighboring lipids,
inverted micelles are formed which encapsulates the peptide into the cell interior.
Disruption of the membrane releases the peptide in the cell. Inverted micelle formations
are highly favored with the presence of hydrophobic and bulky residues. Substituting
tryptophan residues with phenylalanine inhibited formation of inverted micelles (11).
14

The proposed mechanism of antennapedia states that the third helix associates directly to
the membrane by electrostatic interactions (15). The stability of this association enables
the accumulation of the peptide on the membrane surface thereby enhancing the
destabilization of the plasma lipid bilayer into an inverted micelle (Figure 6A) (11),
which then travel and finally open up on the cytoplasmic side.
Pore formation: Molecular dynamics suggest how TaT and arginine rich peptides
translocate the phospholipid bilayer (83). Interaction of the side chains of arginine and
lysines from TaT peptide with the phosphate groups on the lipid bilayer leads to the
accumulation of TaT in the outer leaflet of the bilayer. The bilayer becomes thin as a
result of the peptide accumulation. The attraction between the positive side groups and
the phosphate groups of the distal layer led to pore formation (11).
Carpet-like model: This mechanism was first observed with cationic
antimicrobial peptides that could penetrate into microorganisms leading to cell lysis (84).
Tryptophan promotes this mechanism. It is based on the accumulation of the peptide near
the surface of the cell and at a higher concentration, which then penetrates the cell.

Figure 6: Proposed mechanisms for direct translocation: (A) Inverted micelle, (B)
Pore formation, (C) Carpet like model (86)
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1.5.2. Endocytosis pathways
Clathrin-mediated endocytosis, caveolin-mediated endocytosis, or
clatherin/caveolae-independent endocytosis may also be mechanisms of CPPs uptake.(5,
81) To deliver macromolecules into cells through endocytosis, CPPs must possess certain
characteristics. First, they must be able to associate with the cell surface. They must also
stimulate and undergo efficient internalization via endocytosis. And finally, to be useful
the CPPs must be able to deliver cargos across the lipid bilayer of the endosomal vesicles
into the cytoplasm. This is likely the rate limiting step for intracellular delivery (85). This
pathway can include phagocytosis for the uptake of large particles and macropinocytosis
for solute uptake.
Macropinocyhosis: This process consists of the inward folding of the outer
surface of the plasma membrane directed by actin polymerization (86). The invaginations
result in the formation of macropinosome vesicles which are surrounded by membranes
similar to the cell membrane. Dynamin is responsible for the membrane invagination
(81).
Clathrin-mediated endocytosis: This pathway takes up material into the cell with
the clathrin-coated vesicles. This technique is used by all eukaryotic cells (87). The
functional unit of clathrin is known as a triskelion (88). A triskelion is made up of three
heavy chains and three light chains of clathrin. Interaction of several triskelia enables
clathrin to self-assemble into a regular lattice. Clathrin mediated endocytosis involves
five stages: initiation, cargo selection, coat assembly, scission and uncoating (87) in
which clathrin molecules do not bind directly to the membrane or cargo receptors.
Instead, they form vesicles by binding to membrane adaptor proteins, for example adaptin
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protein 2 (AP2) (88). At initiation, a membrane invagination pit is formed at the plasma
membrane due to the presence of phosphatidylinositol (4,5)-bisphosphate (87). Binding
of the cargo to the receptor triggers the receptors to cluster together and a vesicle will
start to form. Adaptin binds to the tail of the receptors on the cytoplasmic side of the cell
and recruits clathrin. Clathrin then forms a shell around the coat. With the help of
dynamin, the plasma membrane is cleaved and the coated complex is then release into the
cell. The clathrin–adaptin complex falls apart and the cargo can then be transported to its
destination in the cell. Clathrin recycles back to the plasma membrane to be used again.
Endocythosis via caveolin: Caveolae are round small invagination of the plasma
membrane of about 50-80nm in diameter (89) and are enriched with cholesterol and
sphingolipids. They are characterized by an integral membrane protein caveolin which
hold the caveolae in the invagination of the bilayer membrane. Because the N and C
terminals are present in the cytosol, a hydrophobic linker enables caveolin to be
embedded into the plasma membrane.
Caveolae are involved in the internalization of membrane components such as
glycosphingolipids, extracellular ligands like folic acid and albumin, bacterial toxins
including cholera toxin and tetanus toxin, and non-enveloped viruses (89). In this
manner, bacterial and viruses can escape lysosomal degradation enabling use this
pathway as a safer way for drug and DNA delivery (90). Caveolae shape, composition,
and function are cell type dependent (89). They remain attached to the plasma membrane
with the help of the actin cytoskeleton (89). Cargos, for example the SV40 virus, have
been shown to translocate by this pathway (89-91). After binding to the plasma
membrane virions are mobile until trapped by the caveolae. Once in the caveolae, the
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ligand induces the activation of tyrosine kinases followed by a signaling cascade that
results in slow but efficient internalization (89). Phosphorylation enables the
depolarization of actin filaments. Dynamin protein is then recruited which helps to pinch
off the vesicle into the cell.
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2

EXPRESSION AND PURIFICATION OF CPP-ADAPTOR PROTEINS AND
CALMODULIN BINDING PROTEINS
2.1

TaT-CaM Expression

2.1.1 Construction of a vector encoding CPP-adaptor (TaT-CaM)
To generate pure protein for intracellular delivery, a protein expression vector
was constructed. We modified the pET-19b vector with 6× His-tag for purification and
TaT-CaM at the N-terminus as the CPP sequence. The gene of interest could easily be
inserted into pET-19b using NdeI and BamHI restriction sites, which facilitate the
manipulation of various open reading frames (ORFs; Figure 7).

TaT

Calmodulin

His -tag

Figure 7: Schematic representation of recombinant TaT-CaM protein in pET-19b
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2.1.2 Transformation of plasmid into Nova Blue competent cells.
We received 2g of lyophilized plasmid containing the desired construct.
The plasmid was then dissolved in elution buffer (10 mM Tris-HCl, pH 8.5 and 0.1 mM
EDTA). Frozen competent cells were thawed on ice for 5 to 10 min. After addition of
50ng-100ng plasmid DNA to the competent cells, they were incubated on ice for
30minutes. The cells were then placed in a 420C heat bath for 1 minute and then
incubated on ice for 2 minute. One ml of Luria-Bertani (LB) broth was added to the cells.
The cells were incubated at 37 0C for 1 hr with shaking. The cells (100-150μM) were
then plated on an ampicillin/tetracycline resistant LB agar plate and incubated overnight
at 37 0C. The following day, an overnight culture was prepared by inoculating 5ml of LB
medium with a single fresh colony followed by growing cells overnight at 37°C shaking
at 220rpm. The cells were mini-prepped to create working DNA concentrations. All other
constructs were treated the same way to ensure DNA stocks were not lost.
2.2

Ant-CaM Expression

2.2.1

Construction of a vector encoding CPP-adaptor (Ant-CaM)

The Ant-CaM plasmid was created in a similar fashion to that of TaT-CaM but
the coding sequence was inserted into the pET-22b vector. The insertion was also
between NdeI and BamHI in an open reading frame.
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Ant

His -tag

Calmodulin

Figure 8: Schematic representation of recombinant Ant-CaM protein in pET-22b

2.3

TaT-CaM and Ant-CaM purification

The constructed vectors were transformed into BL21 (DE3) pLysS competent
cells (New England Bio Labs) and cells were cultured in LB medium at 370C to an
OD600 nm between 0.4 and 0.6 absorbance. The cells were induced with 0.2 mM
isopropyl-1-thio-β-D-galactopyranoside (IPTG, Sigma-Aldrich). Cells were harvested
using a Sovall R 5C plus centrifuge at 7000rpm at 4 0C. TaT-CaM cells were
resuspended in lysis buffer (10mM Tris-base pH 8.0, 10mM imidazole, 0.05% Tween,
500mM NaCl, 10% glycerol) in the presence of lysozyme and DNase using a vortex and
a homogenizer. The lysis buffer used for Ant-CaM contained 8M urea because the
protein was expressed in inclusion bodies. Hence, unless otherwise stated, all buffers
(wash and elution) used for Ant-CaM contained 8M urea. The homogenized lysates were
broken up using the French press.
The lysates were then separated into supernatant and lysate pellets by
centrifugation at 18,000 rpm. Proteins in the soluble supernatant were purified by HisTagged Talon metal affinity Resin (ClonTech laboratories, CA, USA) according to the
manufacturer's instructions. Briefly, the resin was equilibrated in lysis buffer using a
gravity column. The cleared lysates were incubated with the resin for 30min at 4oC with
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rocking. Protein-resin complex were washed with wash buffer (10mM Tris-base pH 8.0,
25mM imidazole, 0.05% Tween, 500mM NaCl, 10% glycerol) and eluted with elution
buffer (10mM Tris-base pH 8.0, 250mM imidazole, 0.05% Tween, 500mM NaCl, 10%
glycerol). TaT-CaM buffer exchange was performed on the FPLC while Ant-CaM was
carried out using dialysis (2 changes with what difference in volume?which allowed the
protein to refold.

2.4 Calmodulin-binding proteins (CBS-beta-galactosidase, CBS-horseradish
peroxidase, CBS-myoglobin)
2.4.1

Human Beta-Galactosidase (β-gal)

β-gal is a lysosomal enzyme that cleaves the disaccharide lactose into glucose and
galactose. After cleavage, these monosaccharides are able to be used in glycolysis. β-gal
also catalyzes the transgalactosylation of lactose to allolactose (92). In humans, this
protein is encoded by the GLB1 gene and by the lacZ gene in bacteria. Any dysfunction
or deficiency of β-gal will result in the accumulation of
monosialotetrahexosylganglioside (GMI) and keratin sulphate in cells leading to GMI
gangliosidosis and Morquio B metabolic disorders respectively (93).
2.4.2

Horseradish peroxidase (HRP)

HRP is a plant secretory peroxidase that catalyzes the oxidation of various
substrate including aromatic phenols, indoles, phenolic acids, amines, and sulfonates
using H2O2 as the oxidant (94). HRP exists as several isoenzymes in which the
isoenzyme C1A is the most studied (95). This isoenzyme contains a heme-group, two
Ca2+ ions as prosthetic groups, and four disulphide bonds (95). Thermal stability and
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catalytic activities is enforced by the presence of Ca2+. HRP has diverse functions in
medicine including conjugation to antibodies. It is also important as a cancer treatment
target (95).
In this study, we used a truncated synthetic gene that encodes HRP-C1A. This
truncated version lacks the heme group. This gene was used due to the difficulties in
previous expression and purification of recombinant HRP in different expression systems
(96).
2.4.3

Myoglobin (Myo)

Myoglobin is a cytoplasmic hemoprotein that is expressed primarily in the
skeletal and cardiac muscles. Myo was the first protein in which a three-dimensional
structure was determined revealing its highly alpha-helix structure (97, 98). Myoglobin
functions as an oxygen storage hemoprotein- capable of releasing O2 during periods of
hypoxia or anoxia. Myoglobin also acts as a buffer to intracellular O2 concentration when
muscle activity increases and to facilitate intracellular O2 diffusion by providing a path
that increases simple diffusion of dissolved O2. It has been a powerful scavenger of nitric
oxide (NO) and reactive oxygen species (ROS). This implies that Myo might have a role
in cell signaling in mammalian cells since ROS are mediators of cell signals (98,
99). Myo was chosen not only because biochemically it has been highly study, but also
to show the efficiency of our CPP-adaptor translocating both large and small molecules
into the cell.
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2.4 Construction of CBS-protein plasmid
We constructed the vector to express the CBS-proteins by inserting the genes into
the pCAL-n-FLAG vector. The cDNAs of β-gal, HRP, and Myo were inserted between
restriction sites BamHI and HindIII in an open reading frame (Figure 9)

A
CBS-Cargo
CBS

FLAG

Cargo

B

Figure 9: A) Schematic representation of
recombinant CBS-Cargo proteins. B) Commercial
plasmid with a calmodulin binding site (Addgene)

2.5 Expression and purification of CBS-proteins
The expression and purification of CBS-β-gal, CBS-HRP and CBS-Myo were
similar to that of TaT-CaM described above. pCAL-n-FLAG vector encoding the CBSproteins were transformed into BL 21(D3)pLsS. The cells were induced with 0.2mM
IPTG for 4 hours at 300C. Cell pellets were lysed at room temperature in resuspension
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buffer (50mM Tris-base, 150mM NaCl, 1mM EDTA, 1mM DTT, 10% glycerol; pH 7.8)
with lysozyme and DNase using a vortex and a homogenizer. The homogenized lysate
was French pressed to break up the cells. The soluble supernatants were purified over a
calmodulin sepharose resin column on fast protein liquid chromatography (FPLC). The
column was washed with equilibration buffer (50mM Tris-base, 150mM NaCl, 0.1mM
DTT, 2mM CaCl2, 10% glycerol) to remove unwanted proteins. Proteins were eluted
with elution buffer (50mM Tris, 0.1mM DTT, 150mM NaCl, 4mM EDTA, 10%
glycerol). A buffer change was performed by dialysis in CBS buffer (10mM HEPES pH
7.4, 100mM NaCl, 1mM CaCl2, 10% glycerol) or using FPLC.

2.6 SDS-PAGE gel electrophoresis and Western blotting to confirm pure
proteins
TaT-CaM, Ant-CaM and CBS-proteins samples were mixed with SDS-PAGE
sample buffer (20%glycerol, 0.125M Tris-HCl buffer pH 6.8, 2% SDS,0.02%
bromophenol blue) and 5% β-mercaptoethanol to avoid disulfide bridges formation to a
final concentration of 1X. Mixed and denatured samples were heated in a 950C bead bath
for 5mins. They were then loaded onto an SDS casting gel containing a stacking gel on
top (5% polyacrylamide) and a resolving gel on the bottom (15% polyacrylamide). A
constant current of 30mA was applied and the samples were allowed to run until they
migrated to the bottom of the resolving gel. The gels were stained with Coomassie
brilliant blue staining buffer (0.1% Coomassie blue R-250, 45% methanol, 10% acetic
acid) and destained in Coomassie destaining buffer (45% methanol, 10% acetic acid).
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Another set of samples from SDS-PAGE gel were transferred at constant voltage
of 100V onto a nitrocellulose membrane by western blot. The membrane was blocked
with 5% non-fat milk for 1hr and probed with 1:1000 anti-calmodulin (TaT-CaM and
Ant-CaM) and 1:2500 rabbit anti-FLAG (CBS-proteins).

2.7 Results and Discussion
2.7.1

His–tag purification of TaT-CaM and Ant-CaM.

To confirm purification of TaT-CaM and Ant-CaM, the protein was analyzed via
15% SDS-PAGE gel and stained with Coomasie brilliant blue. Western blot probing with
anti-calmodulin also confirms purification (Figure 9). TaT-CaM is expressed and purified
as an active protein compared to TaT protein which is expressed in inclusion bodies
(100). The concentration of TaT-CaM and Ant-CaM were determined using Bradford
assay.

Figure 10: Purification and detection of TaT-CaM (left) and
Ant-CaM (right). Commasie brilliant blue stain (top).
Western blot analysis for TaT-CaM (bottom) probed with
1:1000 anti-Calmodulin rabbit antibody
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2.7.2

Expression and purification of calmodulin binding proteins.

CBS-β-Gal, CBS-HRP, and CBS-Myo were all expressed and purified from BL
9D3) pLysis cells. Western blot analysis was used to confirm purified proteins by probing
with monoclonal anti-FLAG mouse antibody (Sigma) (Figure 11).

Figure 11: Purification of CBS-proteins, probed with 1:1000 anti-Flag mouse
antibody.
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2.8. Circular Dichroism analysis of wild type CaM, TaT-CaM and Ant-CaM
2.8.1. Introduction
To demonstrate that fusing the penetrating peptides TaT and Ant to CaM did not
alter the structure of CaM, we performed circular dichroism (CD) analysis on the purified
TaT-CaM and Ant-CaM with respect to wild type CaM (WT-CaM). CD is a
spectroscopic technique that is used to evaluate the secondary structure or conformational
of macromolecules, folding and binding of proteins in solution (101, 102). CD measures
the difference in absorbance between left and right circular polarized light. The signal
from CD can either be positive or negative depending on which direction light is
absorbed the most. When the left circular polarized light is greater than the right circular
polarized light, CD signals are positive and negative to a lesser extent.
Secondary structures of proteins are determined in the far UV spectral region
(190-250nm). Within these wavelengths, the peptide bond is the chromophore, which
gives rise to a signal when located in a regular and folded environment while in the near
UV (320 -260nm), aromatic amino acid residue are observed (102, 103). Analysis from
CD spectra gives the regular features of alpha-helices and b-sheets (103). Alpha helix
proteins have negative bands at 222 and 208 nm and a positive band at 193 nm (104)
while beta-sheets have a negative band near 218 nm and positive band at 195 nm (105).
Disordered proteins on the other hand have low ellipticity above 210nm and native bands
near 195nm (106).
Protein characterization on CD requires that the protein be at least 95% pure on
SDS-page gel using Coomasie staining. Also, high quality CD data depends on the
protein concentration and the ionic strength of the buffer used. Calmodulin being a Ca2+
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sensor with the ability to bind up to four Ca2+ ions induced a conformational change (45,
57, 107) is made up of highly alpha helix structure. CD analysis showed that in the
presence of Ca2+, the negative alpa-helix peaks are deeper at 222nm and 208nm than in
the absence of Ca2+(87, 108). We analyzed the structures of TaT-CaM and Ant-CaM
using the self-consistent method (SELCON).
2.8.2. Methods and material
All CD experiments were carried out using a JASCO J-710 Spectropolarimer
(JASCO Inc., Tokyo, Japan). Measurements were recorded over wavelengths of 196-250
nm in a 0.1 cm path length cell with a scanning speed of 10nm per minute. Temperature
was controlled at 25oC using a water bath. All samples analyzed were dialyzed into
10mM HEPES (pH 7.4) containing 100mM NaCl, 1mM CaCl2, 0.1% Tween, and 10%
glycerol. The proteins concentrations were adjusted to a final concentration of
0.25mg/mL in the absence of EDTA and 0.25mg/mL in the presence of 5mM EDTA.
2.8.3. Results
The CD spectra of wild type CaM has previously shown peaks in the far UV
region between 195-250nm (87, 101). Comparing the spectra of Ant-CaM and TaT-CaM
with respect to that of wild type CaM, we observed similar patterns with all three
peptides in the absence and presence of EDTA. (Figure 12).
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Table 3: Alpha-Helix content of CAM, Ant-CaM and TaT-CaM
Without EDTA

With EDTA

α-Helix

22%

23%

Ant-CaM

α-Helix

20%

23%

TaT-CaM

α-Helix

18%

15%

13000
8000
3000
0.25mg/ml CaM
0.25mg/ml Ant-CaM
0.25mg/ml TaT-CaM

-2000
-7000
-12000
-17000
-22000
195

215

235

wavelength (nm)

15000
molar ellipticity (deg.cm2/dmol

molar ellipticity (deg.cm2/dmol)

CaM

10000
0.25mg/ml CaM(5mM EDTA)

5000
0

0.25mg/ml Ant-CaM (5mM
EDTA)

-5000
-10000

0.25mg/ml TaT-CaM (5mM
EDTA)

-15000
-20000
-25000
195

215

235

2.8.4. Discussionwavelength (nm)

Figure 12: CD spectra of wild-type CaM, TaT-CaM, and Ant-CaM. Without EDTA (Top plot);
with 5mM EDTA (Bottom plot)
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Using SELCON3 method, we deduced the alpha helix structures of CaM, AntCaM, and TaT-CaM. In this method, the spectrum of the protein analyzed is presented
base on the spectrum of the reference protein having the CD spectrum similar to the
unknown protein. The reference set used for this analysis included in the far UV-region
was SP43 (190nm-240nm).
The results obtained from these measurements showed that in the presence of
Ca2+, alpha- helix structure is enhanced. In the presence of calcium the negative peak
obtained at 222nm and 208nm were deeper than those obtained in the absence of calcium.
These results confirmed that there is not a significant difference between the WT CaM
and the CPP-adaptors. In the presence of Ca2+, TaT-CaM and Ant-CaM spectras are the
same as that of CaM. The disparity of the lines not overlaying is due to protein
concentration. Bearing in mind that the Bradford test only gives an estimate of protein
concentration, a better concentration would have been known if determined by another
technique like quantitative amino acid analysis (101). In the absence of Ca2+, it is
observed that the helix structures are less deep than in the presence of Ca2+. The average
alpha-helix from the regular and the distorted protein are very similar to each other in the
absence and in the presence of EDTA. Therefore Ca2+ enhances the alpha-helix peaks.

2.9.

Summary

Recombinant CBS-proteins were constructed into pCAL-n-FLAG plasmid, while
recombinant TaT-CaM was constructed in pET19b and Ant-CaM in pET-22b. Both CPPadaptor proteins and CBS-proteins were expressed at 30 oC in E. coli BL21 (BDP) using
Luria Broth medium. Proteins expression was induced using IPTG. CBS-proteins were
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purified by affinity chromatography (Calmodulin sepharose resin) and His-tag for TatCaM and Ant-CaM. Purified proteins were identified using Coomasie blue stain dye and
Western blot probing for anti-Flag (CBS-proteins) and anti- Calmodulin (TaT-CaM).
Starting with a liter of culture, the yield of 1ml f TaT-CaM yield was ~16mg while CBSproteins were ~2.0mg. CD analysis further confirmed that covalently linking TaT and
Ant penetrating sequences to calmodulin did not modify the secondary structure of
calmodulin.
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3.

BIOLAYER INTERFEROMETRY AND CELL PENETRATION
ASSAY OF CBS-PROTEINS WITH TAT-CAM

3.1.

Biolayer Interferometry

Biolayer interferometry is a biosensing technique that operates in real time. One
molecule, the ligand is tethered at the tip of the optical biosensor. White light travels
down to the molecule and reflects off. The interference pattern is measured as a shift in
wavelength (Figure 13A). Once a baseline has been established, the senor is then moved
into an analyte containing buffer to monitor association and finally moved into an analyte
free buffer to measure dissociation. Binding of both the ligand and the analyte on the
sensor increases the reflecting surface hence causing a coincident change in the
interference pattern (Figure 13B and Figure 13C) (109)

Figure 13. The biolayer interferometry principle. A) An interference pattern is
established by reflection of white light from two surfaces on a fiber optic sensor with
biotinylated molecules attached to the biolayer. B) Binding of analyte molecules causes a
shift in the wavelength of the interference pattern. C) Monitoring of the interference shift
over time reflects association of analyte with the immobilized molecule. Association is
measured in the presence of analyte and dissociation is measured when the sensor is
moved to buffer containing no analyte. (110)
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BLI measurements were performed on a FortéBio Octet QK biosensor using
streptavidin sensors (SA). Assays were performed in black 96-well microplates at 250C.
All volumes were 200µL. TaT-CaM was biotinylated using NHS-LC-LC-biotin
(succinimidyl-6-[biotinamido]-6-hexanamidohexanoate) (Thermo Scientific, Rockford,
IL, USA) at a 10:1 molar ratio of biotin to protein for 30 min at 250C. Free dye was
separated from reactive biotinylated TaT-CaM by rapid buffer exchange over a desalting
column. After loading biotinylated TaT-CaM onto SA sensors, a baseline was established
in NOS binding buffer prior to association at varying analyte (CBS-proteins)
concentrations. Dissociation was subsequently measured in buffer only and buffer with
10mM EDTA.

3.2.

Cell penetration assay of TaT-CaM with CBS-proteins in BHK 21,

HEK 293T, HT-3 cells by confocal laser scanning microscopy

3.2.1. Confocal Laser Scanning Microscopy (CSLM)
Confocal Laser Scanning Microscopy (CLSM) is a technique used to obtain sharp
images over a narrow depth of field. This is accomplished by eliminating most of the
light from the specimen out of the microscope focal plane. This technique makes it
possible to take thin sections from the sample and build up a two or three-dimensional
image along a vertical axis, a process known as optical sectioning. Confocal laser
scanning microscopy depends on point illumination with a focused laser and a pinhole
detector that rejects out of focus light allowing just the focal point of the sample to be
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detected. When the point illumination excites fluorophores in a region on the sample, out
of focus light is removed by the pinhole detector producing a sharp confocal point (110).
Photons emitted from the sample are detected by a photomultiplier tube and are
analyzed by a computer. An important role of confocal microscopy is the ability to
distinguish between intracellular and extracellular fluorescence without the removal of
fluorescent medium; hence, it can be used to qualitatively evaluate the internalization and
distribution of CPPs in cells.
3.2.2. Cell culture
BHK 21 ATCC cells: Cells were removed from liquid nitrogen storage and placed
in a 370C bead bath for 2min and then closely monitored until they thawed. The cells
were transferred into a 15ml conical containing 5ml Dulbecco’s modified Eagle’s
medium (DMEM) with 10% fetal bovine serum (FBS). Cells were centrifuged for 5min
at 1000 rpm at 300C. BHK 21 cells were re-suspended into 12ml pre-warmed growth
media at 370C and 5% CO2, and then transferred into a T-75 flask. Cells were then
returned into the incubator at 5% carbon dioxide atmosphere, 370C.
Subculturing BHK cells: Cells are maintained as they grow. When cells were
maximally between 80-90% confluent in a T-75 flask, the culture medium is removed
and discarded. The cell layer was quickly rinsed with 0.25% (w/v) Trypsin 0.1%EDTA
solution to remove all traces of serum which contains trypsin inhibitor. Trypsin-EDTA
solution (3ml) was added into the flask and placed in the 370C incubator for 5min and
dispersed cells were observed under a light microscope. Growth media (6ml) was added
into the T-75 flask and the mixture was pipetted gently to mix. The cells in suspension
were then transferred into a 15ml conical tube and centrifuged for 5min at 1000rpm using
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a bench top (Eppendorf 5702HS) centrifuge. Cell pellets were resuspended into 10ml of
growth media and aliquots added into new culture flasks and also in chamber Lab-Tek
cover glass for penetration experiments.

Fluorescently labeled cargos: CBS-proteins were labeled with Dylight aminereactive dye 550 according to the manufacturer’s protocol (Thermo scientific). Briefly,
purified protein (250ul to 500µl) was added into a 50µg dye tube pipetting up and down
then vortexing gently. The mixture was incubated in the dark for 1 hour; then the dye
removal column was used according to the Thermo scientific protocol. This removed the
unreactive dye from the sample. Labeled proteins were aliquoted and stored at -80oC for
future use.
Penetration assay: BHK 21 cells were seeded at 1.2 x104 cells/ml in a 2-well LabTek chambered cover glass (Fisher Scientific) in DMEM medium supplemented with
10%FBS and cultured overnight. The medium was discarded and replaced with fresh
medium. The experimental chamber was treated with TaT-CaM and CBS-cargo at a final
concentration of 1µM each while the control had only CBS-cargo. The chamber culture
plate was incubated for 1 hour at 370C in a 5% CO2 atmosphere. Cells were rinsed three
times with PBS containing calcium and magnesium. The cells were treated with 2 µM
cell tracker green dye (Thermo Fisher) for 20 min with incubation followed by three
rinses with PBS. Cells were stained with a drop of NucBlue for 10min at 37°C. After two
washes with PBS, DMEM/10% FBS medium containing 25mM HEPES pH7.4 buffer
was added into the chambers. Penetration was analyzed using confocal microscopy.
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3.3.

Results and Discussion

3.3.1. BLI assay with TaT-CAM
BLI measurements were performed to analyze protein-protein interaction between
TaT-CaM and nNOS, and CBS-cargos. Biotinylated TaT-CaM was tethered to the SA
sensor. After establishing a baseline in buffer only, the immobilized ligand was dipped
into analyte containing buffer to monitor association and then moved to analyte –free
buffer to monitor dissociation. Interference pattern over time is reported as a wavelength
shift in nanometer. The wavelength shift results in molecules associating and dissociating
from the tip of the biosensor. These real-time experiments enable label-free analysis for
determination of affinity, kinetics and concentration of the analytes. Association and
dissociation experiments are shown in Figure 14 along with simulation fits.
TaT-CaM was first examined for interaction with a natural calmodulin-regulated
protein, nNOS. The binding affinity observed was similar to that of wild type CaM and
nNOS as reported (56) when analyzed with biolayer interferometry. Designing and
synthesizing new cargos with CaM binding sites: CBS-Myo, CBS-HRP, and CBS-β-gal,
the binding affinity and kinetics of these protein-protein interactions were also
determined. All CBS-cargos bound CaM with low nanomolar affinity and had expected
fast-on, slow off kinetics (Figure14A-C). TaT-CaM and cargo proteins dissociated
rapidly upon exposure to EDTA (koff ~ 0.1 s-1, Fig. 14E), indicating that the TaT-CaMCBS interactions function essentially indistinguishably from those of wild type CaM. All
analytes exhibited negligible binding to sensors without TaT-CaM. Rate and affinity
constants determined from single-state global fits are listed in Table 4.
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Table 4: Dissociation Rate constants

KD (nM)

kon (M-1 s-1)

koff (s-1)

nNOS

15

1.2 * 104

1.8 * 10-4

ND

CBS-β-Gal

73

9.2 * 103

6.7 * 10-4

0.05

CBS-HRP

160

1.7 * 103

2.8 * 10-4

0.2

CBS-Myo

0.9

5.9 * 104

5.5 * 10-5

0.09
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koff (EDTA) (s-1)

B

A

1 .5

3900 nM
1000 nM

0 .6

1800 nM

0 .4

n m s h ift

n m s h ift

500 nM
250 nM
125 nM
0 .2

1 .0

900 nM
450 nM
0 .5

225 nM

63 nM
0 .0

0 .0
0

200

400

0

600

200

400

600

T im e (s )

T im e (s )

C

250 nM
1 .0

400 nM

D

4

n m s h i ft

n m s h ift

125 nM
63 nM
0 .5

3

200 nM
2

31 nM

100 nM

1

16 nM

0 .0

50 nM
0

0

200

400

600

0

T im e (s )

E

200

400

600

T im e (s )

% S p e c if ic B i n d in g
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 -G a l
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Figure 14. Binding assay of CBS-proteins with
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3.3.2. BLI assay with Ant-CaM
Purifying Ant-CaM from inclusion bodies using 8M urea, the urea was removed
slowly by dialysis to allow refolding.CD analysis showed the alpha helical structure of
the protein when compared with wild type CaM indicating that the protein folded
properly after dialysis. Optical biosensing experiments similar to TaT-CaM were
performed between Ant-CaM and a nNOS splice variant nNOSmu. AnT-CaM was the
biotinylated ligand while nNOSmu, the analyte. nNOSmu is expressed in skeletal muscles
and has similar catalytic activity as nNOS expressed in the cerebellum (111). nNOSmu
-9

binds CaM with low nanomolar affinity (KD= 3.1x10 M) and expected fast on (Kon=
28303M-1S-1) and slow off rate constants (8.975x10-5S-1) (Figure 15A and B). This
complex rapidly dissociated when moved into 10mM EDTA (Figure 15C). The
dissociation in EDTA is well defined due to the hydrophobic residues present in the
anntenapedia penetration sequence (RQIKIWFQNRRMKWKK). Cell penetration studies
have not been done using Ant-CaM.
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3.3.3. Cell penetration assay in BHK21, HEK 293T, HT-3 cells
As a preliminary measure of the ability of TaT-CaM to mediate uptake of cargo,
neuronal nitric oxide synthase was labeled with Dylite 550 fluorophore and added to
BHK 21 cells in the presence and absence of TaT-CaM. The cells were washed after one
hour. Confocal microscopy showed that in the absence of TaT-CaM labeled nNOS
aggregates were confined to the surface of cells and to the surface of the microscope
slide. TaT-CaM mediated the uptake of almost all the labeled nNOS in less than an hour.
Initially, internalized nNOS was contained in endosomes that appeared to move toward
the nucleus over the next two hours (Figure 16). Considering the fact that nNOS is a large
protein that is difficult to express and purify in E.coli and is very unstable hence cannot
be stored for long term use; we designed, optimized, and synthesized proteins with
calmodulin binding tags.
The initial proteins were chosen in order to show different characteristics ranging
in size, oligomerization and structure. Uptake of cargo into cell interiors was assayed
using an inverted Zeiss (Jena, Germany) LSM700 confocal microscope equipped with a
40x EC Plan-Neofluar objective (NA= 1.3). Z-stacks of both TaT-CaM treated and
untreated cells were acquired and analyzed for incorporation of fluorescently labeled
cargo into the cytoplasm. Orthogonal projections of Z-stacks were generated using Zeiss
ZEN software, which allowed for viewing both treated and untreated cells alike at the
same depth within the cell relative to the diameter of the nucleus. In the presence of TaTCaM, all cargo proteins were delivered to the interiors of the cells and showed significant
cytoplasmic distribution, indicating efficient penetration and escape from endosomes.
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The fluorescently labeled cargo proteins without TaT-CaM showed a very small degree
of adherence to the surfaces of cells, but no penetration into the cell as observed by
absence of fluorescence at the same cytoplasmic depth as that observed in cells treated
with TaT-CaM (Figure 17 -BHK21) and Figure 18 ( HEK 293T and HT-3 cells).

Figure 16: Projection confocal image of labeled nNOS 3 hours
after the onset of TaT-CaM mediated uptake by BHK21 cells.
Nucleus is stained blue; endosomes stained with labeled nNOS in
yellow. Cytoplasm is stained by released nNOS. 3D cross sections
confirm that labeled nNOS is inside the cells.
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Figure 17: Confocal imaging of cell penetration. BHK cells were treated for 1 hour with
fluorescently cargo proteins labeled with DyLight 550 (white in left panel, red channel in
middle and all three channels in right panel), in the absence or presence of TaT-CaM. Cells
were washed and imaged live. Orthogonal projections were generated and the center images
presented are optical sections set at a similar depth of the nucleus (NucBlue staining, white,
right panel), as determined by position within the Z-stack. Scale bars in all panels = 20 μm
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Figure 18: Confocal imaging of cell penetration. HEK 293T and HT-3 cells were treated for 1
hour with fluorescently cargo proteins labeled with DyLight 550 (white in left panel, red channel
in middle and all three channels in right panel), in the absence or presence of TaT-CaM. Cells
were washed and imaged live. Orthogonal projections were generated and the center images
presented are optical sections set at a similar depth of the nucleus (NucBlue staining, white, right
panel), as determined by position within the Z-stack. Scale bars in all panels = 20 μm.
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3.4.

Summary

TaT47-57 sequence (RKKRRQRRR) has been shown to internalize into several cell
types with different cargos. The downside with TaT-sequence internalization is that only
1% of cargos actually reach their destination because they are trapped in the endosomes.
In the past, cargos have escaped the endosomes with the help of peptides such as the pHdependent membrane active peptides (112). Hypothesizing that intracellular calcium
levels would affect calmodulin target proteins, we designed a new CPP-adaptor using the
penetrating TaT sequence conjugated with CaM, TaT-CaM, having a His-tag on the Nterminus for purification. We also designed several prototype calmodulin binding cargos:
CBS-β-gal, CBS-HRP, and CBS-Myo.
Binding kinetics of TaT-CaM-CBS-proteins interaction was obtained using an
optical biosensor. The kinetics of all three protypes was indistinguishable from that
obtained between wild type CaM and eNOS. CBS-cargo proteins bound TaT-CaM
through BLI analysis with sub-nanomolar concentration resulting in a quick on and slow
off rate including the dissociation in EDTA.
Cell penetration assay with confocal laser scanning microscopy analysis showed
uniform distribution of CBS-Myo, CBS-HRP, and CBS-β-gal in the cytoplasm of BHK
21, HEK 298T and HT-3 cells (113). This is an indication that the cargos were not
trapped in the endosomes. Therefore, the prototype, TaT-CaM was able to translocate
cargo proteins of different sizes, overcome the endosomal problem and delivered the
cargo proteins in the cytoplasm of living cells. Therefore, this technology has the
potential to deliver cargos to different organelles given the appropriate localization
signal.
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4.

UPTAKE KINETICS, DOSAGE CONCENTRATION,

CYTOTOXICITY AND SUBCELLULAR LOCALIZATION OF CPPADAPTORS/CARGOS
4.1.

Uptake Kinetics

Kinetics studies of CPPs are an important tool for understanding the uptake
process of cargos. Kinetics explains the rate at which cells take up CPPs and the
maximum quantity taken in can be predicted. Kinetics studies are also essential since they
could provide important ways to elucidate the mechanism by which CPPs go through the
membranes and get into cells. These kinetics measurements can be performed as single
time points or as a function of time.
Single Time Point Measurement: A single time point experiment is one way to
measure the kinetics of CPP internalization in which the amount of internalized CPP is
measured at only one time point. This has the benefit of speed and only a small amount
of used material is lost, however it does not provide kinetic constants thereby limiting the
information derived (114).
Kinetics Measurements as a Function of Time: The amount of internalized CPP
is better obtained as a function of time. Reliable results are obtained when the kinetic data
is collected over a long period of time. At long time intervals, the amount of internalized
CPPs approach equilibrium with that in the surrounding solution. Because the mechanism
of internalization of CPPs is not well known, any kinetic data is either phenomenological
or model based (114).
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For this reason, first-order kinetics is used as a first approximation and the kinetic
parameters are obtained by fitting in the equation the experimental points:
[ A] = [ A ] ∞ ( 1 − e − k t )
Where [A] is the concentration of internalized CPP at time point t, [A]∞ is the final
concentration of CPP inside the cells, and k is the first-order rate constant. Goodness of
fit should be tested the entire time interval of the progress curve and analysis of residuals
should be conducted to detect possible trends in discrepancy between the calculated curve
and the experiment points. If goodness of fit is not satisfactory, then other equations need
to be applied, typically involving more complex internalization mechanisms (114).
We examined the uptake kinetics of TaT-CaM- CBS-Myo complex in BHK cells
and S2 cells at one fixed concentration at different times. The two techniques used for
this analysis were confocal laser scanning microscopy as described in chapter 3 and flow
cytometry, FACs (Fluorescence Activating Cell sorting). Flow cytometry is an important
method of counting, examining and sorting cells in suspension. It allows for the
characterization of physical or chemical attributes of cells as they flow through an optical
detector. Based on this analysis, flow cytometry is able to distinguish a population of
cells based on size, viability, protein expression, fluorescently labelled proteins and
several other features. Here flow cytometry was used to monitor how fast TaT-CaM and
CBS-Myo were taken up by BHK and S2 cells.
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4.1.1

Method

Exponentially growing BHK 21 cells were incubated with cell tracker for 20min
then NucBlue for 10min prior to treatment. Z-Stack positions were set with the cells. The
cells were treated with TaT-CaM and CBS-Myo to a final concentration of 100nM and
images recorded over an hour at 5min intervals. As shown in Figure 19 below, it was
difficult to get real time kinetics for the 1hr time period because penetration was observed
within the first 5min of treatment. We next attempted uptake kinetic studies using the
flow cytometer, BHK cells were trypsinized to lift them up. No kinetics data was
recorded with BHK on the flow because, no penetration was observed. This might be
explained by a key difference in the procedure, trypsinizing the cells may impact the
import machinery found on cell surfaces. We then turned to examine cells already in
suspension in this case S2 cells.
S2 insect cells from Drosophila melanogaster embryos growing at room
temperature at ambient CO2 were used for CPP-adaptor kinetic studies. This is necessary
because trypsinizing adherent cells appears to import machinery of cargos. Untreated
cells were used to set the baseline and gates for the experiment. The cells were treated
with TaT-CaM and CBS-Myo to a final concentration of 500nM
4.1.2.

Results and Discussion

FACS analysis is a conventional tool to quantify cellular association of
fluorochrome-tagged peptides. However, flow cytometry does not discriminate between
membrane-bound and internalized fluorescently labelled cargos, thus limiting the use of
this technique. This limitation is observed with the data in figure 19A with the control at
different incubation periods being similar to the experimental.
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Examination of the time course of TaT-CaM conjugated CBS-Myo uptake using
confocal microscopy showed localization of the CBS-Myo in the cytoplasm within 5mins
(Figure 19 B). Z-stack analysis showed that after five minute, fluorescence becomes
constant. The rapid internalization of the cargos by TaT-CaM suggests that clatherinmediated endocytosis is the mode of entry. Other experiments will be performed to test
this idea.
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Figure 19A. Using FACScan to determine the kinetics of CBS-Myo delivery by TaT-CaM. The
population of S2 cells was gated base on the Forward Scatter (FSC) and side scatter (SSC). From
left to right shows the untreated cells and then treated cells at different time points. The top row
represents CBS-Myo (500nM) control only. The middle row represents cells treated with TaTCaM(500nM) and CBS-Myo (500nM) in 1ml final volume and the last row is cells treated in 5ml
final volume. Each column represents untreat cells, treatment for 5min, 10min, 20min and 30min
respectively
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Figure 19B: Using confocal microscopy to determine the kinetics of CBS-Myo delivery
by TaT-CaM. BHK cells were stained with cell tracker followed by NucBlue. Z-stack
positions were established and then cells were treated with the TaT-CaM-CBS-Myo
complex (100nM). Images were obtained over 1hr at 5mins interval. In summary, no
significant change is observed after 5mins of treatment.

51

4.2.

Dose Concentration and Cytotoxicity

4.2.1. Dose concentration
We initially used 1µM final concentration of both TaT-CaM and cargos to test
penetration. To find out the minimum dose that is effective, we tested 3 different
concentrations 1nM, 100nM and 500nM. Confocal images showed penetration with all
three concentrations Figure 20.
4.2.2. Cytotoxicity
High concentrations of TaT peptide initiate apoptosis in endothelial cells (112).
For TaT-CaM to be used as a therapeutic delivery tool, it must be well tolerated; we
analyzed higher concentrations of TaT-CaM to determine the impact on cellular health.
BHK cells were treated as in Figure 21 and pictures were taken 48h after incubation with
the indicated concentrations. For all concentrations, there was no change in morphology
with the BHK cells. This implies that TaT-CaM is not toxic to cells even at a 50 fold
increase from our standard concentration of 1µM ((113).
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Figure 20: Dose concentration showing three different TaT-CaM and
CBS-Myo (A) 1nM, (B) 100nM, (C) 500nM concentrations. BHK cells
were treated with various concentrations of CBS-Myo with or without
TaT-CaM for 15mins. Cells were washed 3x with PBS followed by
incubation in 2uM cell tracker green dye for 20min. Washed 3x then
Nucblue staining for 10min. Imaged in 25mM HEPES pH 7.4 medium.
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Figure 21: Dose concentration

of TaT-CaM

checking for cytoxicity. BHK cells were treated with
various TaT-CaM concentrations as listed on the images
and pictures were taken after 48h. No significant changes
in morphology were noted.
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4.3.

Subcellular localization of TaT-CaM and CBS-cargos in the Nucleus

and Endoplasmic Reticulum
Subcellular localization signals determine the environments in which
eukaryotic proteins reside. Subcellular localization influences protein function by
controlling access to and availability of all types of molecular interaction partners.
Therefore, knowledge of protein localization often plays a significant role in
characterizing the cellular function of hypothetical and newly discovered proteins.
Subcellular location of a protein can be determined either by mass spectrometry (where
cellular organelles are analyzed for protein composition) (115) or by protein labeling.
The latter is then analyzed by fluorescence microscopy.
The nucleus is the major cellular component where transcription of genes take
place, and it is the major target for drugs. However, transport of therapeutic molecules
from cytoplasm to the nucleus remains a challenge. Studies on the nuclear pore complex
have enabled CPPs to be designed with nuclear import signal sequences. These
sequences, nuclear localization sequences (NLSs), are characterized by short sequences
with at least one or two clusters of four or more basic amino acids (116). The most
common sequence used is the monopartite NLS, PKKKRKV, derived from simian virus
40 (SV40) large T antigen. This NLS has been used to couple cargoes such as proteins,
peptides and DNA, allowing these coupled proteins to cross the nuclear membrane (116).
The endoplasmic reticulum (ER) is the organelle in eukaryotic cells where
proteins are folded. Synthesized proteins are transported in vesicles to the Golgi
apparatus and other organelles. Most lipids that are used for the membranes of the
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mitochondria and peroxisomes are also synthesized in the ER. Signal sequences were
first used to direct the polypeptide chain emerging from ribosomes to a translocator on
the ER membrane. Forming a pore in the membrane, the polypeptide was able to
translocate into the lumen of the ER (117). This signal sequence also helps to ensure that
proteins exported from the cell or those being delivered to specialized organelles reached
the ER lumen. With the ER signal sequence, KDEL, attached to any cargo protein, the
protein is retained to the ER. Proteins with this sequence will only leave the ER after the
sequence has been cleaved off by signal peptidases (117)
To test subcellular localization, we designed CBS-Myo with NLS and KDEL
sequences. We designed CBS-Myo-NLS and CBS-Myo- KDEL with the idea that if these
localization signals are successful, then proteins will be able to be delivered into these
organelles using TaT-CaM.
Cell penetration assay with TaT-CaM
Sub-localization analysis of TaT-CaM was performed by fluorescently labelling
TaT-CaM protein with Dylight 550 according to the manufacturer’s protocol and as
described in chapter 3. BHK cells were treated with 100nM labeled TaT-CaM for 15min.
The cells were washed three times with PBS containing calcium and magnesium.
Localization was observed with confocal microscopy. Using cell tracker dye (green) to
stain the cytoplasm and NucBlue for the nucleus, we were able to identify TaT-CaM in
the endosomes (Figure 22).
These results were confirmed with fixed cells. Briefly, BHK cells were treated
with TaT-CaM complex with CBS-Myo. The cells were washed 3 times with PBS then
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fixed with 4% PFA + 0.1% Triton-X-100 with rocking at room temperature for 20min.
The cells were blocked with PBS/5% BSA for an hour. The fixed cells were probed
overnight at 400C with anti-calmodulin 1:1000 dilution. TaT-CaM localization was
observed using the secondary antibody, goat anti-rabbit Alexa 488 (1:200). The control
for this test was probing for untreated cells with anti- calmodulin testing for endogenous
calmodulin.
Labelled TaT-CaM

Green cytoplasmic
dye

NucBlue

Merge with NucBlue

TaT-CaM

Merge with
NucBlue

Figure 22: BHK cells were treated with TaT-CaM in live cells (A) or fixation (B).
Nucleus and cytoplasm were stained with NucBlue and cell-tracker green dye
respectively. A) Live cells treated with labeled TaT-CaM (red) for 15mins. B) Cells
after incubation with TaT-CaM were fixed in 4% PFA for 20mins then blocked in
PBS/5% BSA + 0.1% Triton-X-100.
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Cell penetration Assay with CBS-Myo-NLS
BHK cells were treated for 20 minutes with CellTracker Green CMFDA dye
(rendered as green) followed by two PBS/Ca2+washes. They were again treated for 10
minutes with NucBlue (rendered as blue).The cells were treated with 100nM of Dylight
550 fluorescently labeled cargo protein CBS-Myoglobin-NLS (rendered as red) in buffer
containing 1 mM CaCl2, either in the presence or absence of 100nM TaT-CaM for 30min.
Afterwards the cells were washed and imaged by fluorescence confocal microscopy. Zstacks were set using the NucBlue staining of the nucleus as a reference. Orthogonal
projections of Z-stacks were generated using Zeiss Zen software. As shown in Figure
(Figure 23), CBS-Myo-NLS in the presence of TaT-CaM is entering into the cell, and is
being transported via the nuclear pore complex into the nucleus.

Figure 23: Confocal imaging of cell penetration. BHK cells were treated for 20 minutes with
CellTracker Green CMFDA dye (green in left panels). Then treated for 10 minutes with
NucBlue. Then treated with 100nM DyLight 550 fluorescently labeled cargo protein CBSMyo-NLS (rendered as red) in either the absence or presence of 100nM TaT-CaM.
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Cell penetration Assay with CBS-Myo-KDEL
BHK cells were treated for 20 minutes with CellTracker DEeep Red dye
(rendered as magenta). The cells were then treated for 20 minutes with ER dye (rendered
as green) followed by a 10 minutes NucBlue treatment (rendered as white). The cells
were then treated with 100nM of Dylight 550 fluorescently labeled cargo protein CBSMyo-KDEL (rendered as red) in buffer containing 1 mM CaCl2, either in the presence or
absence of 100nM TaT-CaM for 30min. Afterwards the cells were washed and imaged by
fluorescence confocal microscopy. Z-stacks were set using the NucBlue staining of the
nucleus as a reference. Orthogonal projections of Z-stacks were generated using Zeiss
Zen software. As shown in Figure 24, CBS-Myo-KDEL in the presence of TaT-CaM is
entering into the cell, and is localizing in the ER.

Figure 24. Confocal imaging of cell penetration. BHK cells were treated for 20 minutes with
CellTracker Deep red dye (magenta in left panels) followed ER dye for 20min (green). Then, treated
for 10min with NucBlue. Cells were treated with 100nM DyLight 550 fluorescently labeled CBSMyo-KDEL( red), in either the absence or presence of 100nM TaT-CaM for 15 min.
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4.4.

Summary

We attempted to examine the uptake kinetics of TaT-CaM with cargo complex by
BHK cells. With confocal microscopy, after the first 5min, the results did not change
upon TaT-CaM/CBS-Myo addition. This suggests that penetration occurs within 5min of
TaT-CaM treatment. Attempting to visualize uptake faster using flow cytometry,
trypsinized BHK cells were used to flow on the FACs, but no penetration was observed.
We think that trysin impacts the cell uptake machineries. Using insect cells growing in
suspension, it was difficult to analyze uptake versus surrounding since controls looked
just like experimentals. A re-evaluation is required on how to evaluate uptake kinetics. A
possibility is using a microfluidics chamber on the confocal microscope and imaging
cells during treatment.
We also performed both labeling and immunohistochemistry to identify the
location of TaT-CaM when it let go of cargos in the cell. The data suggests TaT-CaM
location to be in the endosomes. Using the nuclear and the ER subcellular localization
sequences, preliminary studies showed that CBS-Myo-NLS and CBS-Myo-KDEl in the
presence of TaT-CaM were transported into the nucleus and ER respectively.
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5.

APPLICATIONS OF CPP-ADAPTORS AND FUTURE
DIRECTIONS

As stated, one of the aims of this project was to design new cell penetrating
peptide-adaptors that would be used for the internalization of biological molecules.
Macromolecular compounds, like proteins, oligonucleotides and polypeptides consist of
capabilities and therapeutic features that are highly sought after. However, large
macromolecule intracellular delivery in vivo has not been realized because they have low
to no bioavailability and require delivery vehicles. Even though multiple classes of
delivery vehicles have been developed and significant progress has been made, there are
still inadequate robust and safe uptake formulations. The ability of CPPs to translocate
rapidly into cells is being exploited and this technique has led to the delivery of a broad
range of therapeutics including proteins, DNA, antibodies, oligonucleotides, imaging
agents and liposomes in a variety of situations and biological systems. Previous CPPs
have shown great potential and have even been used in the treatment of human diseases
such as neuronal disease, asthma, ischemia, diabetes, and cancer (113) however
inefficient endosomal escape has remained a major challenge. Our CPP-adaptor has
overcome this challenge unleashing an unlimited number of possibilities and
applications.
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Covalently linked small molecules to CPPs have shown proof of concept of
optimal delivery. However, attaching CPPs to small molecules may not be the best
method for the delivery of all types of therapeutic molecules. Covalent coupling to a
peptide could interfere with the function of biologically active molecules, for example
oligonucleotides and proteins, possibly by causing steric hindrance of drug binding to
targets. Therefore, for macromolecule cargoes, non-covalent CPP complexes might
provide a better drug delivery solution.
Protein delivery by CPPS
Proteins and peptides have significant potential as theraputics for the treatment of
various human diseases including storage diseases and cancer. Storage diseases are those
that are caused by the deficiency of certain enzymes especially lysosomal enzymes (118)
and they can be treated only by administering exogenous enzymes. These enzymes and
other proteins have been coupled to CPPs for delivery. CPPs deliver proteins ranging in
size from 30kDa (GFP) to 150KDa (IgG). Therapeutic relevant proteins have been
delivered by CPPs and they have significant potential in cancer and stroke treatment
(119).
Drug delivery by CPPs in cancer cells

One relevant clinical application of CPPs is the delivery of drug for conventional
cancer chemotherapeutics as well as oligonucleotide based treatments. Due to CPPs
ability to transport cargos through the cellular plasma membrane, a large number of
different drug-CPP constructs have been synthesized. The cargos, that have been
delivered, range from classical molecular drugs to different types of oligonucleotides and
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proteins. For example, in cancer chemotherapy, toxic drugs are conjugated to CPPs and
delivered more efficiently than previous drug administration methods (120).

TaT, penetratin, and several other CPPs have been use to deliver chemotherapy
drugs into tumor cells. One such example is doxorubicin (DOX), a drug commonly used
to treat various types of cancers. Even though DOX has been used to treat many different
cancers, it has difficulty crossing the blood brain barrier. This brain barrier challenge is
due to the tight endothelial cell junctions at the blood brain barrier. Coupling DOX to
CPPs, the uptake was 20 fold higher into the brain parenchyma than free DOX (121).
Another anticancer agent, Methotrexate (MTX) which is not frequently used due to tumor
cell resistance, was delivered into tumor cells using the CPP YTA2 (122). MTX-CPP
was successfully delivered into tumor cells, hence overcoming MTX resistance in the
breast cancer cell line MDA-MB-321, thereby restoring the effect of MTX and rendering
the tumor cells once again sensitive for chemotherapy (122).

Delivery of Macromolecules by CPPs for tumor targeting
CPPs used in gene therapy are able to condense DNA tightly into a small
compact particle. The particle should be able to target the condensate to specific cell
surface receptors and finally be able to escape the endosomal trap and target the DNA
cargo into the nucleus for gene expression (29). TaT has been fused at the N-terminal
domain of the tumor suppressor protein p53 leading to accumulation of p53 in cells and
the activation of apoptotic genes. TaT coupled to an anti-p21 antibody was used to block
p21 from translocating into nucleus thereby making cancer cells more sensitive to
chemotherapy hence reducing the dosage of chemotherapy used (29). Using CPPs to
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deliver antibodies directly into the cytoplasm and nucleus of cancer cells has incredible
potential, allowing for the intracellular targeting of cancer-specific protein mutations.
Delivery of imaging agents
The ability to visualize internal features of living organisms and observe cellular
functions in vivo has the potential to improve disease management by detecting disease
markers, diagnosing, and treating diseases. Imaging technologies also make it easy to
detect the stage of diseases, identify the extent of disease and measure the effect of
treatment. Magnetic resonance imaging (MRI) is the most used imaging technique on soft
tissue. Images are obtained based on nuclei exposure to a static magnetic field. Other
imaging agents are required to image angiogenesis, and apoptosis, but again permeability
of these imaging agents remains a challenge. CPPs again have been used in this field to
deliver imaging agents, contrast agents and quantum dots (QDs) (1).

We designed optimized and developed TaT-CaM and Ant-CaM. Fluorescently
labeled calmodulin binding site proteins: CBS-Myo, CBS-HRP, CBS-β-gal were
delivered into eukaryotic cells (BHK, HEK 293T, HT3). Because endosomal entrapment
has been a significant problem for CPP delivery, we analyzed cargo delivery with an
inverted confocal microscope and were able to detect the cargos in the cytoplasm of the
cells. Further analysis revealed that after delivery of cargos, TaT-CaM was entrapped in
the endosomes. This indicates selective delivery of cargos and that after TaT-CaM has
completed its function it will be broken down and removed from the cell. The work
described so far was achieved using micromolar concentrations. This represents an
optimal concentration between the CPP-adaptor and the cargos giving the CPP-adaptor
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the ability to promote endosomal escape and deliver cargoes at higher rates. This is
significant because a lower concentration of drugs can be used when an optimal CPPadaptor is used therefore, reducing toxicities and side effects.

CPPs applications are widely used as drug delivery tools because they are low in
cytotoxicity. Comparative cytotoxicity studies between the basic (TaT and penetratin)
and amphipathic peptides (transpotan and MAP) showed that amphipathic peptides have
been associated with membrane leakage (114). These analyses using lactate
dehydrogenase confirmed that transportan and MAP were involved in membrane leakage
that was associated with the hydrophobic residues in these peptides. On the other hand,
basic peptides were mild in toxicity.

Another application of CPPs in cancer treatment involves small anticancer drugs
being able to diffuse into cancer cells directly. The only issue with this is that after
repeated exposure of the same drug a tumor cell could develop multidrug
resistance (115). CPP-adaptors would be very promising in this area since they are able to
deliver both small and large molecules. By delivering a mixture of both small and large
molecules the CPP could postpone the development of multidrug resistance in tumor
cells. CPPs have also been used to improve internalization across the blood barrier of the
brain (116). Considering the work, we showed with subcellular localization, our CPPadaptors are eligible to internalize any cargo into a specific organ or tissue as long as it
has the localization signal.
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Future directions

The first objective of this study was achieved. Moving forward, we would alter
the environment of a cell by using the CPP-adaptor to penetrate an active kinase in the
cell. Numerous diseases are associated with stress responses. The cellular stress response
includes unfolded or misfolded protein accumulation and organelle deterioration. Thus,
enhanced activation of pathways that have evolved to protect against these defects may
protect against degenerative diseases such as Parkinson’s and Alzheimer’s (123).
Generally, stress response pathways are maintained in the off state or at a baseline level.
The perturbation of an organelle or stimulation from external stimuli would activate these
pathways. Once activated, they stayed on to efficiently promote cellular survival and
organelle recovery. When the stimuli are removed, the pathways are regulated so that
cells can properly respond to future stress. For example, the p38 MAPK pathway also
known as p38 SAPK (Stress Activated Protein Kinase) protein kinase is activated by
different stress stimuli. p38 plays a key role in the regulation of cellular responses to
many types of stresses, and also in the regulation of proliferation, differentiation, survival
and development of specific cell types (124-126).

The JNK pathways are another example of a stress activating pathway. JNK
activities strongly increase in response to different stresses such as cytokines, UV
irradiation, growth factor deprivation, and agents that interfere with DNA and protein
synthesis (126). JNKs are also involved in stress-induced and developmentally
programmed apoptosis as well as cell transformation (126). Examining the cytotoxicity of
CPPs, TaT-peptide and antennapedia results showed that at higher concentrations, stress
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response pathways, JNK and p38 are activated with JNK being more severe than p38
(127). Treating cells with TaT-CaM and finding out if stress response pathways are
turned on will be an interesting finding. Our toxicity results of BHK cells treated with
50µM TaT-CaM showed no morphology change after 48hrs. We will analyze these stress
pathways by treating the cells with TaT-CaM and probing the cell lysates to determine
the activities of p38 and /or JNK kinases. Also, we will shuttle an active p38 or JNK
kinase into cells and monitor activity.
This work has demonstrated the feasibility of delivery of a variety of cargo
proteins and has opened up an array of potential research in diagnostic and therapeutic
applications. Another area of investigation includes the mechanism of internalization.
Knowing that TaT-CaM delivery cargos escaped endosomal trap, it would be important
to understand if the TaT-CaM/ CBS-proteins are fully enveloped in the endosomes or it is
sitting on the endosomal membrane with TaT-CaM in the vesicle and CBS-proteins
outside. This can be achieved by organelle isolation. Endosomes can be extracted and
treated in the presence and absence of proteinase K. If it is in the vesicle, then more will
be observed in the plus proteinase K treated. But if it is outside, then more will be seen in
the negative proteinase K treated.
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